Treatment of Severe Atopic Dermatitis with Cyclosporine: A Review of Eight Patients

1. Kang K, Polster AM, Nedorost ST, Stevens SR, Cooper KD. Atopic dermatitis. In: Bolognia JL, Jorizzo JJ. Dermatology. London: Elsevier; 2008.Search in Google Scholar

2. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis): part I. J Eur Acad Dermatol Venereol 2012;26(8):1045-60.10.1111/j.1468-3083.2012.04635.x22805051Search in Google Scholar

3. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis): part II. J Eur Acad Dermatol Venereol 2012 ;26(9):1176-93.10.1111/j.1468-3083.2012.04636.x22813359Search in Google Scholar

4. Darsow U, Wollenberg A, Simon D, Taieb A, Werfel T, Oranje A, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010;24(3):317-28.10.1111/j.1468-3083.2009.03415.x19732254Search in Google Scholar

5. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129(4):422-30.10.1111/j.1365-2133.1993.tb03170.x8217757Search in Google Scholar

6. van Joost T, Heule F, Korstanje M, van den Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130(5):634-40.10.1111/j.1365-2133.1994.tb13111.x8204472Search in Google Scholar

7. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44-7.Search in Google Scholar

8. Czech W, Bräutigam M, Weidinger G, Schöpf E. A body-weightindependent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol 2000;42(4):653-9.Search in Google Scholar

9. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000;142(1):52-8.10.1046/j.1365-2133.2000.03241.x10651694Search in Google Scholar

10. Zurbriggen B, Wüthrich B, Cachelin AB, Wili PB, Kägi MK. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis: a double-blind, singlecentre, cross-over pilot study. Dermatology 1999;198(1):56-60.10.1159/00001806510026403Search in Google Scholar

11. Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, et al. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens. Br J Dermatol 1996;135(Suppl 48):15-20.10.1111/j.1365-2133.1996.tb00704.x8881899Search in Google Scholar

12. Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. Clin Exp Allergy 2004;34(4):639-45.10.1111/j.1365-2222.2004.1907.x15080819Search in Google Scholar

13. Haeck IM, Knol MJ, Ten Berge O, van Velsen SG, de Bruin-Weller MS, Bruijnzeel-Koomen CA. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011;64(6):1074-84.10.1016/j.jaad.2010.04.02721458107Search in Google Scholar

14. Kwakkel-van Erp JM, Haeck IM, Paantjens AW, van de Graaf EA, van Ginkel WG, Knol MJ, et al. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. J Am Acad Dermatol 2010;63(3):e70-2. 10.1016/j.jaad.2010.02.01520708466Search in Google Scholar

15. Schmitt J, Schäkel K, Fölster-Holst R, Bauer A, Oertel R, Augustin M, et al. Prednisolone vs. ciclosporin for severe adult eczema: an investigator-initiated double-blind placebocontrolled multicentre trial. Br J Dermatol 2010;162(3):661-8.10.1111/j.1365-2133.2009.09561.x19863501Search in Google Scholar

16 Arellano FM, Wentworth CE, Arana A, Fernandez C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 2007;127:808-16.10.1038/sj.jid.570062217096020Search in Google Scholar

17. Hagstromer L, Ye W, Nyren O, Emstestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005;141:1123-7.10.1001/archderm.141.9.112316172309Search in Google Scholar

18. Dinić M, Kandolf Sekulović L, Mladenović T, Zečević R. Erythrodermic cutaneous T-cell lymphomas: two case reports. Serb J Dermatol Venereol 2009;1(3):116-21, 19. Bos JD, Leent EJ, Sillevis-Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998;7:132-8.10.1111/j.1600-0625.1998.tb00313.x9758407Search in Google Scholar